Stock Ticker

  • Loading stock data...

Moderna Inc (NASDAQ:MRNA) Proposes Multi-Billion Dollar Investment To Increase Vaccine Production By Three Times To Combat COVID-19 Pandemic: The US Government Invests $230 Million

Moderna Inc (NASDAQ:MRNA) would triple its vaccine manufacture with a multibillion-dollar investment. It is necessary to combat the growing menace of coronavirus across the world in 2022. Doubles raw materials production The company will ensure the availability of higher doses of vaccines in 2022 to protect the world population from coronavirus. Moderna can increase the manufacture […]

Regular Allows Moderna Inc (NASDAQ:MRNA) To Fill About 15 Doses Per Vaccine Vial

Moderna will start speeding up its COVID-19 vaccine output after getting a nod from the U.S. Food and Drug Administration (FDA). The company swings into action, filling each vial with about 15 doses. The United States is concerned about spreading the deadly virus and channeling resources to support rapid immunization activities. The nod The drug […]

Johnson & Johnson (NYSE:JNJ) Enrols 45,000 Subjects in the Study of Its Experimental COVID-19 Vaccine Candidate

Johnson & Johnson (NYSE:JNJ) has said that it enrolled around 45,000 participants for its late stage study of its single-dose COVID-19 vaccine candidate and anticipates interim data at the end of January 2021. ENSEMBLE Study enrolls 45,000 participants The pharmaceutical company seems to lag rivals such as Moderna Inc. (NASDAQ:MRNA) and Pfizer Inc. (NYSE:PFE) in […]

Merck (NYSE:MERK) Quits RSV Vaccine Development With Moderna (NASDAQ:MRNA), But Will Continue Oncology Collaboration

Merck & Co Inc. (NYSE:MERK) is returning all rights to the respiratory syncytial virus (RSV) vaccine to Moderna Inc. (NASDAQ:MRNA) barely after helping take the vaccine into the clinic. The vaccine dubbed mRNA-1172 used Merck’s lipid nanoparticle delivery. Merck to hand over RSV rights to Moderna The pharmaceutical company is doubling down on its in-house […]

Pfizer Inc. (NYSE:PFE) And BioNtech (NASDAQ:BNTX) Partners With Rentschler To Purify mRNA-Based COVID-19 vaccine

Pfizer Inc. (NYSE:PFE) and BioNtech (NASDAQ:BNTX) have partnered with Germany contract development band manufacturing organization, Rentschler Biopharma. The partnership is for the purification process of their mRNA-based SARS-CoV-2 vaccine, BMNT1762b2. Rentschler to purify Pfizer and BioNtech’s COVID-19 vaccine drug substance The companies are conducting late-stage clinical studies of the vaccine and expect to release data […]

Moderna Inc (NASDAQ:MRNA) Triggers Hype In Wall Street After Coronavirus Vaccine Announcement But Critics Cry Faul

Moderna Inc (NASDAQ:MRNA) recently revealed that the preliminary results of its coronavirus vaccine trial have yielded positive results leading to a surge in its stock price, but the announcement also yielded some criticism. The U.S-based biotech revealed that the initial results of its coronavirus vaccine were promising. This was enough to encourage positive sentiments regarding […]

Moderna Inc. (NASDAQ:MRNA) Releases Positive Data For Its Coronavirus Vaccine Candidate In Human Trials

Moderna Inc. (NASDAQ:MRNA) has released positive data from its first human trials for its COVID-19 vaccine candidate, demonstrating that the healthy volunteers who received the vaccine developed antibody responses. Moderna’s vaccine in humans shows positive immunity response The company which had partnered with the National Institute of Health in developing the vaccine indicated that there […]